This white paper will explore how COVID-19 pushed the industry to adapt to tech-enabled solutions for patients and sponsors.

Key takeaways include:

  • The importance of decentralized/hybrid trial models and remote monitoring in current and future studies.
  • What regulatory changes were brought into effect during the pandemic that will change the future of research.
  • How innovations in technology were used to support clinical research during the pandemic in order to keep trials on track and make future trials more efficient.